Medicinova Inc 's Revenue in the fiscal year 2025 $ 0.41 millions
Medicinova Inc 's Revenue in the fiscal year 2024 $ 0.00 millions
Medicinova Inc 's Revenue in the fiscal year 2023 $ 1.00 millions
Medicinova Inc 's Revenue in the fiscal year 2022 $ 0.00 millions
Medicinova Inc 's Revenue in the fiscal year 2021 $ 4.04 millions
MNOV Revenue second quarter 2026 Y/Y Growth Comment
Medicinova Inc achieved in the second quarter 2026, above Company average Revenue surge of 252.65% year on year, to $ 0.46 millions.
Looking into second quarter 2026 results within Major Pharmaceutical Preparations industry 45 other companies have achieved higher Revenue growth. While Medicinova Inc ' s Revenue doubling of 252.65% ranks overall at the positon no. 317 in the second quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Medicinova Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
158.21 %
-30.12 %
-100 %
(Jun 30 2012)
MNOV's II. Quarter Q/Q Revenue Comment
Medicinova Inc achieved in the II. Quarter 2026 above company average sequential Revenue doubling of 141.28%, to $ 0.46 millions, from $0.19 millions in the first quarter. MNOV is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Major Pharmaceutical Preparations industry 21 other companies have achieved higher Revenue quarter on quarter growth. While Medicinova Inc 's Revenue growth quarter on quarter, overall rank is 107.
Medicinova Inc achieved in the II. Quarter 2026 above company average sequential Revenue doubling of 141.28%, to $ 0.46 millions, from $0.19 millions in the first quarter. MNOV is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Major Pharmaceutical Preparations industry 21 other companies have achieved higher Revenue quarter on quarter growth. While Medicinova Inc 's Revenue growth quarter on quarter, overall rank is 107.
Medicinova Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 30 2026)
12 Months Ending (Mar 31 2026)
12 Months Ending (Dec 31 2025)
12 Months Ending (Sep 30 2025)
12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending
$ 0.92
$ 0.60
$ 0.00
$ 0.00
$ 0.00
Y / Y Revenue Growth (TTM)
-
-
-
-
-
Year on Year Revenue Growth Overall
Ranking
#
#
#
#
#
Seqeuential Revenue Change (TTM)
54.28 %
-
-
-
-
Seq. Revenue Growth (TTM) Overall
Ranking
# 320
# 0
# 0
# 0
# 0
Cumulative Revenue growth Comment
Medicinova Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 252.65% year on year, to $ 1 millions if the fiscal year would have ended in Jun 30 2026. Medicinova Inc 's trailing twelve months Revenue growth was higher than company's average 0% and higher than % growth in Mar 31 2026. And, Medicinova Inc realized the fastest Revenue growth, in Major Pharmaceutical Preparations industry. But from twelve months ended Mar 31 2026 rise was beneth at 54.28 % from $0.6 millions achieved in the period from Mar 31 2026 to Jun 30 2025. Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at 0%.
Medicinova Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .
Medicinova Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 252.65% year on year, to $ 1 millions if the fiscal year would have ended in Jun 30 2026. Medicinova Inc 's trailing twelve months Revenue growth was higher than company's average 0% and higher than % growth in Mar 31 2026. And, Medicinova Inc realized the fastest Revenue growth, in Major Pharmaceutical Preparations industry. But from twelve months ended Mar 31 2026 rise was beneth at 54.28 % from $0.6 millions achieved in the period from Mar 31 2026 to Jun 30 2025. Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at 0%. The momentum is even more impressive from twelve months ended Mar 31 2026 exhibited at 54.28 % increase from $0.6 millions in the period from Mar 31 2026 to Jun 30 2025.
Medicinova Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .
About Medicinova Inc Revenue Growth Rates (MNOV), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
408.65%